medigraphic.com
Boletín Clínico de la Asociación Médica del Hospital Infantil del Estado de Sonora

2016, Number 1

<< Back Next >>

Bol Clin Hosp Infant Edo Son 2016; 33 (1)

Enfermedad de Mano, Pie y Boca en Niños

Rodríguez-García R, Rodríguez-Silva R, Aguilar-Ye A

Language: Spanish
References: 24
Page: 3-8
PDF size: 235.33 Kb.


ABSTRACT

Objective: Submit a series of clinical cases of the hand, foot and mouth disease in Mexican children.
Material and Methods: Series of clinic cases selected in a pediatric service, during summer-autumn 2014, in southern Veracruz.
Results: We studied 19 clinical cases. Were 16 (79%) male. The ages of the children ranged from 6 to 48 months old. All the children had ulcers in the oral mucosa and eruptions in palm of the hand and soles of the feet. Most of the children had fever 18 (94.73%), hyporexia 17 (89.4%) and persistent crying 16 (84.2%). There were no complications, or hospitalizations.
Discussion: Hand, foot and mouth disease in children is a common illness that has been presented in outbreaks during the past five years in the south Veracruz, Mexico.


REFERENCES

  1. 1.- Wang YR, Sun LL, Xiau WL, Wang XF, Pan DM. Epidemiology and clinical characteristics of hand foot, and mouth disease in a Shenzhen sentinel hospital from 2009 to 2011. BMC Infectious Diseases 2013; 13: 539. doi: 10. 1186/1471-2334- 13-539.

  2. 2.- Huang J, Wang J, Bo Y, Xu C, Hu M, Huang D.Identification of Health Risks of Hand, Foot and Mouth Disease in China Using the Geographical Detector Technique.Int J Environ Res Public Health 2014; 11: 3407-23.

  3. 3.- Liu B, Luo L, Yan S, Wen T, Bai W, Li H, et al. Clinical Features for mild hand, foot and mouth disease in China. PLoS ONE 2015; 10: (8): e015503.doi: 1371/journal.pone. 0135503.

  4. 4.- Zhang X, Wang H, Ding S, Wang X, Chen X, Wo Y, et al. Prevalence of enteroviruses in children with and without hand, foot, mouth disease in China. BMC Infect Dis 2013; 13: 606. doi: 10.1186/1471-2334-13-606.

  5. 5.- Delgado AW, Concha CH, Guevara CJO. Infección de la mucosa oral por Coxsackie virus: enfermedad de boca-manopie. Rev Estomatol Herediana 2007; 17: 35-9.

  6. 6.-Robinson CR, Doane FW, Rhodes AJ. Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957-isolation of group A Coxsackie virus. Canad Med Assoc J 1958; 79: 615-21.

  7. 7.- Dalldorf G, Sickles GM, Plager H, GiffordR.A virus recovered from the feces of poliomyelitis patients pathogenic for suckling mice.J ExpMed 1949; 89: 567-82.

  8. 8.-Martínez EV, Laureano LM. Enfermedad mano-pie-boca. Presentación de un caso y breve revisión de la literatura. Rev Cent Dermatol Pascua 1999; 8: 21-4.

  9. 9.- Tan CW, Lai JK, Sam IC, Chan YF. Recent developments in antiviral agent agaist enterovirus 71 infection. J biomedSci 2014 feb 12 ;21: 14. doi: 10.1186/1423-0127-21-14.

  10. 10.- Larralde M, Aristizábal AM. Enfermedad de mano-pie-boca. Arch Argent Dermatol 2005; 55: 25-9.

  11. 11.- Bo Y, Song C, Wang J, Li X. Using an autologistic regression model to identify spatial risk factors and spatial risk patterns of hand, foot and mouth disease (HFMD) in Mainland China. BMC Public Health 2014; 14: 358-86.

  12. 12.- Machain WC, Dzul RA, Yeh GA, Rodriguez RK, Noh PH, Talavera AL, et al. Detection of hand, foot and mouth disease in the Yucatan Peninsula of Mexico. Infect Dis Rep 2014; 6: 62-4.

  13. 13.- Gürkan A, Akar M, Senel S. Características demográficas de pacientes con enfermedad pie-mano-boca. Serie de casos atípicos. Arch Argent Pediatr 2015; 113; e211-e4.

  14. 14.- Liu J, Zhang GL, Li L, Li C, Wang M, Liang X, et al. Therapeutic effect of Jinzhen oral liquid for hand foot mouth disease: a randomized, multi-center, double-blind, placebo-controlled trial. PLoS ONE. 2014 Apr 10;9(4):e94466. doi: 10. 1371/journal.pone.0094466. eCollection 2014.

  15. 15.- Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, et al. An Inactivated Enterovirus 71 vaccine in healthy children.New Eng J Med 2014; 370: 829-37.

  16. 16.- Oliveras CP. Enfermedad de la boca la mano y el pie. EnfermPediatr 2012; 4: 11-2.

  17. 17.- Nicola AC, Malpica DR. Enfermedad de boca-mano-pie y virus Coxsackie. Reporte de un caso. Multiciencias 2012; 12: 300-4.

  18. 18.- Liu W, Wu S, Xiong Y, Li T, Wen Z, Yan M, et al. Co-circulation and genomic recombination of Coxsackievirus A16 and Enterovirus 71 during a large outbreak of hand, foot and mouth disease in Central China.PLoS ONE 2014; 28: 9(4): e96051. doi: 10.1371/journal.pone.0096051.

  19. 19.- Buttery VW, Kenyon C, Grunewald S, Oberste MS, Nix WA. Atipycal presentations of hand, foot and mouth disease caused por Coxsackievirus A6-Minnesota 2014. MMWR Morb Mortal Wkly Rep 2015; 64: 805.

  20. 20.- Sinclair C, Gaunt E, Simmonds P, Broomfield D, Nwafor N, Wellington L, et al. Atypical hand, foot, mouth disease associated with Coxsackievirus A6 infection, Edinburg, United Kingdom, January and February 2014. Euro Surveill 2014; 19(12): 20745.

  21. 21.- Shelley WB, Hashim M, Shelley ED. Acyclovir in the treatment of hand-foot-and-mouth disease. Cutis 1996; 57: 232- 4.

  22. 22.- Faulkner CF, Godbolt AM, DeAmbrosis B, Triscott J. Hand, foot and mouth disease in an immunocompromised adult treated with acyclovir. Australas J Dermatol 2003; 44; 203-6.

  23. 23.- Hu P, Hou S, Du P, Li J, Ye Y. Paroxysmal supraventricular tachycardia in an infant with hand, foot and mouth disease. Ann Dermatol 2012; 24: 200-2.

  24. 24.- Zhang HP, Wang L, Qian JH,Cai K, Chen Y, Zang Q, et al. Efficacy and safety of ribavirin aerosol in children with handfoot- mouth disease. ZhongguoDangDai Er KeZaZh2014; 16: 272-6. 8




2020     |     www.medigraphic.com